IL53271A - Pharmaceutical compositions for the treatment of hypertension comprising tripeptides of the thyrotropin releasing hormone type - Google Patents

Pharmaceutical compositions for the treatment of hypertension comprising tripeptides of the thyrotropin releasing hormone type

Info

Publication number
IL53271A
IL53271A IL53271A IL5327177A IL53271A IL 53271 A IL53271 A IL 53271A IL 53271 A IL53271 A IL 53271A IL 5327177 A IL5327177 A IL 5327177A IL 53271 A IL53271 A IL 53271A
Authority
IL
Israel
Prior art keywords
tripeptides
hypertension
treatment
pharmaceutical compositions
releasing hormone
Prior art date
Application number
IL53271A
Other versions
IL53271A0 (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL53271A0 publication Critical patent/IL53271A0/en
Publication of IL53271A publication Critical patent/IL53271A/en

Links

IL53271A 1976-11-08 1977-11-01 Pharmaceutical compositions for the treatment of hypertension comprising tripeptides of the thyrotropin releasing hormone type IL53271A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73968576A 1976-11-08 1976-11-08
US82212777A 1977-08-05 1977-08-05

Publications (2)

Publication Number Publication Date
IL53271A0 IL53271A0 (en) 1978-01-31
IL53271A true IL53271A (en) 1981-01-30

Family

ID=27113562

Family Applications (1)

Application Number Title Priority Date Filing Date
IL53271A IL53271A (en) 1976-11-08 1977-11-01 Pharmaceutical compositions for the treatment of hypertension comprising tripeptides of the thyrotropin releasing hormone type

Country Status (1)

Country Link
IL (1) IL53271A (en)

Also Published As

Publication number Publication date
IL53271A0 (en) 1978-01-31

Similar Documents

Publication Publication Date Title
KE3175A (en) Pharmaceutical compositions for use in the suppression of gastric reflux
PT67009A (en) Processes for the preparation of pharmaceutical compositions
JPS51118839A (en) Amino acid pharmacy for liverish patient dosage
ZA781599B (en) Peptides which effect release of hormones
ZA7671B (en) Pharmaceutical composition
JPS5272829A (en) Pharmaceutical composition
JPS5219658A (en) Novel peptide compound
GB1541275A (en) Pure thymic hormone
IL60406A (en) Tripeptides which are structural analogues of thyrotropin releasing hormone,process for preparing same and pharmaceutical compositions comprising same
PH14723A (en) Pharmacologically active compounds and compositions containing same
ZA763917B (en) Pharmaceutical compositions and compounds
MY7800259A (en) N-(perfluoroalkanoyl)-n-phosphonomethyl glycine compounds
JPS5492938A (en) Peptide compound*its manufacture and medicine
ZA76186B (en) Stabilized quick set adhesives
NZ184281A (en) Hydantoin derivatives and pharmaceutical compositions
PH14141A (en) Pharmaceutical composition containing dipeptide derivatives
HK61079A (en) Lhrh peptide derivatives
NZ187638A (en) Peptides and pharmaceutical compositions
MY8600617A (en) Pharmaceutical compositions
ZA773935B (en) Peptide derivatives and pharmaceutical compositions containing same
NZ184735A (en) Peptides and pharmaceutical compositions
JPS51118739A (en) Preparation of ll33*3*4 dihydroxyyphenyl**22methyll alanine peptide
IL49122A (en) L-pyroglutamyl-l-histidyl-3-alkyl-prolineamide processes for their preparation and therapeutic compositions containing the same
ZA761324B (en) Pharmaceutically active compounds
GB1539317A (en) Processes for the preparation of an antidiuretically active vasopressin